American Journal of Obstetrics & Gynecology
Volume 201, Issue 1 , Pages 12.e1-12.e8 , July 2009

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

  • Andra H. James, MD

      Affiliations

    • Women's Hemostasis and Thrombosis Clinic, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprints: Andra H. James, MD, Women's Hemostasis and Thrombosis Clinic, Duke University Medical Center, Durham, NC 27710
    • ,
  • Peter A. Kouides, MD

      Affiliations

    • University of Rochester General Hospital, Rochester, NY
    • ,
  • Rezan Abdul-Kadir, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, Royal Free Hospital, London, UK
    • ,
  • Mans Edlund, MD, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, Danderyds Sjukhus AB, Stockholm, Sweden
    • ,
  • Augusto B. Federici, MD

      Affiliations

    • Angelo Bianchi Bonomi Haemophilia Thrombosis Centre, IRCCS Maggiore Policlinico Hospital, Mangiagalli and Regina Elena Foundation and University of Milan, Milan, Italy
    • ,
  • Susan Halimeh, MD

      Affiliations

    • MVZ Labor Duisburg GmbH, Clinical Consultations for Coagulation and Haemophilia Disease, Duisburg, Germany
    • ,
  • Pieter W. Kamphuisen, MD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Barbara A. Konkle, MD

      Affiliations

    • Penn Comprehensive Hemophilia and Thrombosis Program, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Oscar Martínez-Perez, MD, PhD

      Affiliations

    • Gineguirurgica S.L., Las Rozas, Madrid, Spain
    • ,
  • Claire McLintock, MD

      Affiliations

    • University of Auckland, Auckland, New Zealand
    • ,
  • Flora Peyvandi, MD, PhD

      Affiliations

    • Angelo Bianchi Bonomi Haemophilia Thrombosis Centre, IRCCS Maggiore Policlinico Hospital, Mangiagalli and Regina Elena Foundation & University of Milan, Milan, Italy
    • ,
  • Rochelle Winikoff, MD

      Affiliations

    • CHU Ste-Justine, Montreal, University of Montreal, QC, Canada

Received 14 September 2008 ,Revised 5 March 2009 ,Accepted 9 April 2009.

References 

  1. Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause. J Womens Health Gend Based Med. 2002;11:39–44
  2. Acute pain management: operative or medical procedures and trauma: clinical practice guideline). Washington, DC: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services; 1992;
  3. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171–232
  4. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia. 2002;8:607–621
  5. Lee CA, Chi C, Pavord SR, et al. The obstetric and gynaecological management of women with inherited bleeding disorders: review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia. 2006;12:301–336
  6. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5:40–48
  7. Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6:643–648
  8. Ragni MV, Bontempo FA, Hassett AC. Von Willebrand disease and bleeding in women. Haemophilia. 1999;5:313–317
  9. Federici AB, Mannucci PM. Management of inherited von Willebrand disease in 2007. Ann Med. 2007;39:346–358
  10. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004;111:734–740
  11. Biron C, Mahieu B, Rochette A, et al. Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. J Lab Clin Med. 1999;134:605–609
  12. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454–459
  13. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993;123:893–898
  14. von Willebrand EA. Hereditar pseudohemofili. Finska Lakarsallskapets Handl. 1926;67:7–112
  15. Hundegger R, Husslein P, Berghammer P, Egarter C, Kyrle A. Postpartum bleeding and von Willebrand's disease. Arch Gynecol Obstet. 2002;266:160–162
  16. Kadir RA, Kingman CE, Chi C, Lee CA, Economides DL. Is primary postpartum haemorrhage a good predictor of inherited bleeding disorders?. Haemophilia. 2007;13:178–181
  17. Burlingame J, McGaraghan A, Kilpatrick S, Hambleton J, Main E, Laros RK. Maternal and fetal outcomes in pregnancies affected by von Willebrand disease type 2. Am J Obstet Gynecol. 2001;184:229–230
  18. Caliezi C, Tsakiris DA, Behringer H, Kuhne T, Marbet GA. Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3. Haemophilia. 1998;4:845–849
  19. Chediak JR, Alban GM, Maxey B. Von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol. 1986;155:618–624
  20. Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol. 1986;68:282–285
  21. Foster PA. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey: on behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995;74:784–790
  22. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. BJOG. 1991;98:909–918
  23. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. BJOG. 1998;105:314–321
  24. Lak M, Peyvandi F, Mannucci PM. Cli and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol. 2000;111:1236–1239
  25. Ramsahoye B, Davies S, Dasani H, Pearson J. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia. 1995;1:140–144
  26. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost. 2007;5:1165–1169
  27. Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia. 2003;9:292–297
  28. Silwer J. Von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl. 1973;238:1–159
  29. Hoveyda F, MacKenzie IZ. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG. 2001;108:927–930
  30. Lee CY, Madrazo B, Drukker BH. Ultrasonic evaluation of the postpartum uterus in the management of postpartum bleeding. Obstet Gynecol. 1981;58:227–232
  31. Roque H, Funai E, Lockwood CJ. Von Willebrand disease and pregnancy. J Matern Fetal Med. 2000;9:257–266
  32. Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005;3:2619–2626
  33. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost. 2006;4:766–773
  34. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss: a population study: variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45:320–351
  35. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol. 2004;190:1216–1223
  36. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. BJOG. 1990;97:734–739
  37. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351:485–489
  38. Mikhail S, Varadarajan R, Kouides PA. The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre. Haemophilia. 2007;13:627–632
  39. Drews CD, Dilley AB, Lally C, Beckman MG, Evatt B. Screening questions to identify women with von Willebrand disease. J Am Med Womens Assoc. 2002;57:217–218
  40. Sramek A, Eikenboom JC, Briet E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med. 1995;155:1409–1415
  41. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost. 1999;82:1456–1461
  42. Mandalaki T, Louizou C, Dimitriadou C, Symeonidis P. Variations in factor VIII during the menstrual cycle in normal women [letter]. N Engl J Med. 1980;302:1093–1094
  43. Miller CH, Dilley AB, Drews C, Richardson L, Evatt B. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb Haemost. 2002;87:1082–1083
  44. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric-based population: comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost. 2000;84:401–409
  45. Favaloro EJ, Bonar R, Kershaw G, et al. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process. Haemophilia. 2004;10:232–242
  46. Nitu-Whalley IC, Riddell A, Lee CA, et al. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thromb Haemost. 2000;84:998–1004
  47. Favaloro EJ, Thom J, Baker R. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi- laboratory survey. Blood Coagul Fibrinolysis. 2000;11:729–737
  48. Federici AB, Canciani MT, Forza I, Cozzi G. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: single center comparison of four different assays. Thromb Haemost. 2000;84:1127–1128
  49. Alperin JB. Estrogens and surgery in women with von Willebrand's disease. Am J Med. 1982;73:367–371
  50. Philipp CS, Dilley A, Miller CH, et al. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost. 2003;1:477–484
  51. Miller CH, Haff E, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost. 2003;1:2191–2197
  52. Kouides PA, Heit JA, Philipp CS, et al. A multi-site, prospective cross-over study of intranasal desmopressin and oral tranexamic acid in women with menorrhagia and abnormal laboratory hemostasis [abstract]. Blood. 2007;110:711
  53. Kingman CE, Kadir RA, Lee CA, Economides DL. The use of levonorgestrel-releasing intrauterine system for the treatment of menorrhagia in women with inherited bleeding disorders. BJOG. 2004;111:1425–1428
  54. Sanchez-Luceros A, Meschengieser SS, Marchese C, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis. 2003;14:647–651
  55. Wickstrom K, Edelstam G, Lowbeer CH, Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004;64:31–40
  56. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16:153–168
  57. Prendiville WJ, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: active versus physiological management of third stage of labour. BMJ. 1988;297:1295–1300
  58. World Federation of Hemophilia. Report on the WFH Global Survey 2005 [cited February 18, 2008]. http://www.wfh.org/2/7/7_0_Link7_GlobalSurvey2005.htmAccessed Feb. 18, 2008
  59. Working group on “rare bleeding disorders”. Rare bleeding disorder database [Internet; cited February 18, 2008]. http://www.rbdd.orgAccessed Feb. 18, 2008
  60. Lukes AS, Kadir RA, Peyvandi F, Kouides PA. Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact. Fertil Steril. 2005;84:1338–1344
  61. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia. 2005;11:295–307

 Financial support for this meeting was provided by CSL Behring, Marburg, Germany.

 Cite this article as: James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009;201:12.e1-8.

PII: S0002-9378(09)00410-4

doi: 10.1016/j.ajog.2009.04.024

American Journal of Obstetrics & Gynecology
Volume 201, Issue 1 , Pages 12.e1-12.e8 , July 2009

Article Tools

* Image Usage & Resolution